Work

Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial

Year: 2013

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: The Lancet Diabetes & Endocrinology

DOI: 10.1016/s2213-8587(13)70113-x

Authors: Agnès Hartemann, Gilbert Bensimon, Christine A Payan, Sophie Jacqueminet, Olivier Bourron, Nathalie Nicolas, Michèle Fonfrede, Michelle Rosenzwajg, Claude Bernard, David Klatzmann

Institutions: Pitié-Salpêtrière Hospital, CIC Paris-est, Centre National de la Recherche Scientifique, Inserm, Assistance Publique – Hôpitaux de Paris, Immunologie - Immunopathologie - Immunothérapie, Université Pierre-et-Marie-Curie

Language: English

Topic: Diabetes and associated disorders

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2106107076

FWCI: 13.43

Cites: 30

Cited by: 447

Related to: 10